Axon Enterprise’s (AXON) “Market Outperform” Rating Reaffirmed at JMP Securities

JMP Securities reiterated their market outperform rating on shares of Axon Enterprise (NASDAQ:AXONFree Report) in a report published on Tuesday, Benzinga reports. They currently have a $375.00 price objective on the biotechnology company’s stock.

A number of other analysts have also issued reports on AXON. Needham & Company LLC reissued a buy rating and issued a $400.00 price target on shares of Axon Enterprise in a research report on Tuesday. The Goldman Sachs Group lifted their target price on shares of Axon Enterprise from $297.00 to $339.00 and gave the company a buy rating in a research note on Wednesday, February 28th. Barclays increased their price objective on Axon Enterprise from $296.00 to $308.00 and gave the stock an overweight rating in a report on Thursday, February 29th. Morgan Stanley lifted their price objective on Axon Enterprise from $285.00 to $310.00 and gave the company an equal weight rating in a research report on Friday, April 26th. Finally, William Blair reaffirmed an outperform rating on shares of Axon Enterprise in a research report on Wednesday, April 24th. Two analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of Moderate Buy and a consensus target price of $327.00.

Read Our Latest Analysis on AXON

Axon Enterprise Trading Down 4.6 %

Axon Enterprise stock opened at $312.73 on Tuesday. The company has a 50 day moving average price of $310.77 and a 200 day moving average price of $267.13. The company has a debt-to-equity ratio of 0.42, a quick ratio of 2.66 and a current ratio of 3.00. Axon Enterprise has a 52 week low of $175.37 and a 52 week high of $329.87. The firm has a market capitalization of $23.60 billion, a price-to-earnings ratio of 135.97 and a beta of 0.91.

Axon Enterprise (NASDAQ:AXONGet Free Report) last issued its quarterly earnings results on Monday, May 6th. The biotechnology company reported $1.15 earnings per share for the quarter, beating analysts’ consensus estimates of $0.95 by $0.20. The business had revenue of $460.74 million for the quarter, compared to the consensus estimate of $441.57 million. Axon Enterprise had a return on equity of 14.11% and a net margin of 11.14%. Axon Enterprise’s revenue for the quarter was up 34.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.51 earnings per share. Research analysts forecast that Axon Enterprise will post 2.44 EPS for the current year.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in AXON. Norges Bank bought a new stake in Axon Enterprise during the fourth quarter worth approximately $195,406,000. Sands Capital Management LLC grew its stake in Axon Enterprise by 31.1% in the 3rd quarter. Sands Capital Management LLC now owns 2,612,305 shares of the biotechnology company’s stock valued at $519,823,000 after buying an additional 619,179 shares during the last quarter. Westfield Capital Management Co. LP raised its holdings in Axon Enterprise by 184.3% in the 3rd quarter. Westfield Capital Management Co. LP now owns 696,193 shares of the biotechnology company’s stock worth $138,535,000 after acquiring an additional 451,350 shares during the period. Polar Capital Holdings Plc lifted its position in Axon Enterprise by 292.0% during the 3rd quarter. Polar Capital Holdings Plc now owns 265,464 shares of the biotechnology company’s stock worth $52,825,000 after acquiring an additional 197,746 shares during the last quarter. Finally, International Assets Investment Management LLC bought a new stake in Axon Enterprise during the fourth quarter valued at about $39,907,000. 79.08% of the stock is owned by institutional investors.

Axon Enterprise Company Profile

(Get Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Read More

Analyst Recommendations for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.